A detailed history of Brevan Howard Capital Management LP transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 14,232 shares of IART stock, worth $314,954. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,232
Holding current value
$314,954
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$17.14 - $31.74 $243,936 - $451,723
14,232 New
14,232 $258,000
Q1 2024

May 15, 2024

BUY
$33.4 - $45.2 $209,985 - $284,172
6,287 New
6,287 $222,000

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.85B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.